Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Journal of Attention Disorders|August 30, 2012
Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device?Peter M Wehmeier, Laura Kipp, Tobias Banaschewski, et al.Plos One|September 3, 2025
Minimizing Urban Carbon Emissions and Heat Island Intensity: A theoretical studyFabian Reitemeyer, Fabiano L Ribeiro, Jan Schwarz, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 10, 2007
Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophreniaPeter M Wehmeier, Michael Kluge, Edith Schneider, et al.European Child & Adolescent Psychiatry|May 26, 2009
Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescentsPär Svanborg, Gunilla Thernlund, Per A Gustafsson, et al.Pharmaceutical Statistics|May 19, 2015
Structured Benefit-risk assessment: a review of key publications and initiatives on frameworks and methodologiesShahrul Mt-Isa, Mario Ouwens, Veronique Robert, et al.Pain Practice : the Official Journal of World Institute of Pain|January 28, 2014
Antidepressants in the treatment for chronic low back pain: questioning the validity of meta-analysesOwen D Williamson, Doron Sagman, Robert H Bruins, et al.Neuropsychiatric Disease and Treatment|January 28, 2015
Efficacy comparison of duloxetine and SSRIs at doses approved in JapanEiji Harada, Alexander Schacht, Tsukasa Koyama, et al.Bioresource Technology|March 11, 2014
An ultra-low energy method for rapidly pre-concentrating microalgaeTeodora Rutar Shuman, Gregory Mason, Michael D Marsolek, et al.Journal of Child and Adolescent Psychopharmacology|November 2, 2011
Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking devicePeter M Wehmeier, Alexander Schacht, Christian Wolff, et al.Expert Opinion on Drug Safety|June 21, 2012
Tolerability aspects in duloxetine-treated patients with depression: Should one use a lower starting dose in clinical practice?Stefan Wilhelm, Frank G Boess, Ulrich Hegerl, et al.Pageof 7